Skip to Content

Revvity Inc

RVTY: XNYS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
$943.00VdxrfkCftmfhbly

PerkinElmer Reports Strong Q1 Results Based on COVID-19 Tailwinds; No FVE Change

Narrow-moat PerkinElmer reported strong first-quarter results, delivering overall revenue of about $1.3 billion, beating our and FactSet consensus expectations on the top and bottom lines. Unsurprisingly, the company experienced another quarter of solid growth, nearly up 100% from 2020, mainly driven by the ongoing demand for its COVID-19-related testing solutions. We are maintaining our narrow moat rating and $106 fair value estimate.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of RVTY so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center